Answers are grounded in this paper and cite their sources.
Introduction: Worldwide, the affected population with erectile dysfunction (ED) is predicted to increase from 152 millions in 1995 to 322 millions in 2025. Aim of the work: The aim of this study was to assess the impact of improvement of glycosylated hemoglobin on erectile function in type II diabetic men with erectile dysfunction. Patient and Methods: This is prospective study, which was performed from September 2016 to February 2018 at the department of urology at Minia urology and nephrology hospital. Fifty male patients with ED included in this study and presented at Andrology Outpatient clinic. Results: The study was done at Minia Urology and Nephrology University Hospital, fifty participants were enrolled from Andrology outpatient's clinic whose were complaining of erectile dysfunction and diagnosed as type II diabetes mellitus more than 5 years duration, all patients under treatment for glycemic control.
No takes yet. Share an insight, caveat, or question.
Husain et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: